GNARLY BRANDS, LLC – Trademark Portfolio
Entity Type: 16
GNARLY BRANDS, LLC holds 42 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 40 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 19 trademarks are registered and 1 is pending. Notable registered marks include FUEL2O, GNARLY WHEY, GNARLY BCAAS, GNARLY VEGAN, and GNARLY HYDRATE. The owner is based in Salt Lake City, UT.
650 S 500 W Ste 161
Salt Lake City, UT 84101
Showing of trademarks Trademarks
Trademark Classifications
GNARLY BRANDS, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does GNARLY BRANDS, LLC have?
GNARLY BRANDS, LLC has 42 U.S. trademarks filed with the USPTO. Of these, 19 registered, 1 pending, 9 abandoned, 13 cancelled.
What trademark classes does GNARLY BRANDS, LLC file in?
GNARLY BRANDS, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 33 (Wine & Spirits). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GNARLY BRANDS, LLC's most well-known trademarks?
GNARLY BRANDS, LLC's registered trademark portfolio includes well-known marks such as FUEL2O, GNARLY WHEY, GNARLY BCAAS, GNARLY VEGAN, and GNARLY HYDRATE. These are among 19 currently registered trademarks in the portfolio.
What is GNARLY BRANDS, LLC's trademark registration success rate?
GNARLY BRANDS, LLC has a 46% trademark registration rate, with 19 out of 41 resolved applications resulting in successful registration. Currently, 1 application is pending review.